UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
August 24, 2022
Accession Number:
Submission Type:
CIK:
0001766140
Company Name:
Unicycive Therapeutics, Inc.
File Number:
333-266890